IMPROVING MEDICATION PRESCRIBING AND UTILIZATION IN THE NURSING-HOME

被引:112
作者
GURWITZ, JH
SOUMERAI, SB
AVORN, J
机构
[1] HARVARD UNIV,SCH MED,DEPT SOCIAL MED,BOSTON,MA 02115
[2] BETH ISRAEL HOSP,DEPT MED,BOSTON,MA 02215
关键词
D O I
10.1111/j.1532-5415.1990.tb02406.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
There is ample and compelling evidence to suggest that medications are frequently used inappropriately in the nursing home. The occurrence of avoidable adverse drug reactions is the most serious consequence of inappropriate prescribing; economic implications are also of interest. With increasing concern over the quality of care in nursing homes, and with the revision of regulations governing such care by the Health Care Financing Administration, it is important to consider the experience thus far in monitoring and improving drug use in nursing homes. A number of studies have investigated approaches designed to reduce inappropriate prescribing and drug utilization in this setting. In contrast to the wide range of approaches that have been evaluated and implemented in the hospital setting, interventions in the nursing home have centered primarily around consultant‐pharmacist activities. Although these activities are now federally mandated in all nursing homes, there is little evidence from adequately controlled studies to document their impact or cost‐effectiveness. By contrast, face‐to‐face educational interventions directed at physicians (“academic detailing”) have been shown to be effective in improving prescribing for some medications. The prominent role played by the nursing staff in the utilization of many medications in the nursing home implies that an educational intervention excluding nursing staff would be insufficient to influence drug utilization positively in many situations (eg, psychoactive medications and laxatives). Future research efforts must pay greater attention to adequate study design considerations as well as to the clinical outcomes of such interventions and their cost‐effectiveness. 1990 The American Geriatrics Society
引用
收藏
页码:542 / 552
页数:11
相关论文
共 92 条
[1]   NURSING-HOME INFECTIONS - THE CONTEXT [J].
AVORN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (13) :759-760
[2]   INCREASED ANTIDEPRESSANT USE IN PATIENTS PRESCRIBED BETA-BLOCKERS [J].
AVORN, J ;
EVERITT, DE ;
WEISS, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (03) :357-360
[3]   SCIENTIFIC VERSUS COMMERCIAL SOURCES OF INFLUENCE ON THE PRESCRIBING BEHAVIOR OF PHYSICIANS [J].
AVORN, J ;
CHEN, M ;
HARTLEY, R .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (01) :4-8
[4]   PSYCHOACTIVE MEDICATION USE IN INTERMEDIATE-CARE FACILITY RESIDENTS [J].
BEERS, M ;
AVORN, J ;
SOUMERAI, SB ;
EVERITT, DE ;
SHERMAN, DS ;
SALEM, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (20) :3016-3020
[5]   MODEL FOR DRUG-USE REVIEW IN A SKILLED NURSING FACILITY [J].
BRODIE, DC ;
LOFHOLM, P ;
BENSON, RA .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1977, 17 (10) :617-&
[6]  
BROWN CH, 1980, CONTEMP PHARM PRACT, V3, P209
[7]   PSYCHOTROPIC-DRUG PRACTICE IN NURSING-HOMES [J].
BUCK, JA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (05) :409-418
[8]  
CAMPBELL DT, 1963, EXPT QUASI-EXPT DESI
[9]   OVERMEDICATION OF THE LOW-WEIGHT ELDERLY [J].
CAMPION, EW ;
AVORN, J ;
REDER, VA ;
OLINS, NJ .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (05) :945-947
[10]  
CASTLEDEN CM, 1977, BRIT MED J, V1, P1